TCTC Holdings’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.5M Buy
369,627
+700
+0.2% +$53.9K 0.76% 34
2025
Q4
$29.3M Sell
368,927
-600
-0.2% -$47.3K 0.87% 28
2025
Q3
$27.9M Sell
369,527
-2,750
-0.7% -$188K 0.83% 31
2025
Q2
$25.7M Buy
372,277
+63
+0% +$4.13K 0.83% 31
2025
Q1
$25.2M Sell
372,214
-7,600
-2% -$455K 0.89% 31
2024
Q4
$17M Sell
379,814
-10,535
-3% -$591K 0.61% 44
2024
Q3
$24.5M Sell
390,349
-25,556
-6% -$1.49M 0.83% 29
2024
Q2
$24.6M Sell
415,905
-31,694
-7% -$1.98M 0.84% 28
2024
Q1
$35.7M Sell
447,599
-945
-0.2% -$72.2K 1.19% 18
2023
Q4
$35.4M Sell
448,544
-9,599
-2% -$683K 1.29% 16
2023
Q3
$32M Sell
458,143
-7,891
-2% -$559K 1.23% 16
2023
Q2
$32.2M Sell
466,034
-3,680
-0.8% -$262K 1.29% 17
2023
Q1
$34.9M Buy
469,714
+8,293
+2% +$695K 1.41% 15
2022
Q4
$43M Buy
461,421
+950
+0.2% +$91.7K 1.75% 11
2022
Q3
$43.9M Sell
460,471
-427
-0.1% -$42.3K 1.9% 10
2022
Q2
$42.7M Buy
460,898
+2,465
+0.5% +$241K 1.88% 10
2022
Q1
$46.4M Sell
458,433
-4,261
-0.9% -$448K 1.91% 11
2021
Q4
$47.7M Sell
462,694
-1,000
-0.2% -$92.4K 2.04% 12
2021
Q3
$39.3M Sell
463,694
-2,010
-0.4% -$168K 1.82% 12
2021
Q2
$38.9M Buy
465,704
+933
+0.2% +$76.4K 1.78% 12
2021
Q1
$35M Buy
464,771
+1,728
+0.4% +$126K 1.66% 14
2020
Q4
$31.6M Sell
463,043
-2,799
-0.6% -$182K 1.69% 15
2020
Q3
$27.2M Buy
465,842
+65,392
+16% +$4.07M 1.68% 16
2020
Q2
$26M Sell
400,450
-2,198
-0.5% -$138K 1.54% 15
2020
Q1
$23.9M Buy
402,648
+4,391
+1% +$293K 1.8% 13
2019
Q4
$29.6M Sell
398,257
-230
-0.1% -$16.1K 1.52% 13
2019
Q3
$25.1M Sell
398,487
-2,467
-0.6% -$146K 1.32% 15
2019
Q2
$21.8M Buy
400,954
+31,702
+9% +$1.71M 1.19% 19
2019
Q1
$19.9M Buy
369,252
+29,145
+9% +$1.8M 1.08% 24
2018
Q4
$22.3M Sell
340,107
-598
-0.2% -$44.6K 1.24% 16
2018
Q3
$26.8M Buy
340,705
+916
+0.3% +$65.5K 1.23% 14
2018
Q2
$21.9M Buy
339,789
+30,554
+10% +$2.01M 1.06% 21
2018
Q1
$19.2M Buy
309,235
+93,000
+43% +$6.67M 1.02% 26
2017
Q4
$15.7M Buy
216,235
+192,625
+816% +$14M 0.82% 30
2017
Q3
$1.92M Buy
23,610
+1,875
+9% +$148K 0.12% 74
2017
Q2
$1.75M Buy
21,735
+2,191
+11% +$173K 0.12% 75
2017
Q1
$1.53M Buy
19,544
+19
+0.1% +$1.52K 0.09% 90
2016
Q4
$1.54M Buy
19,525
+11,565
+145% +$936K 0.09% 90
2016
Q3
$708K Sell
7,960
-300
-4% -$28.3K 0.05% 98
2016
Q2
$791K Hold
8,260
0.05% 110
2016
Q1
$857K Hold
8,260
0.05% 108
2015
Q4
$807K Buy
8,260
+202
+3% +$19.8K 0.05% 108
2015
Q3
$777K Buy
8,058
+1,628
+25% +$171K 0.04% 112
2015
Q2
$674K Sell
6,430
-1,600
-20% -$163K 0.04% 113
2015
Q1
$829K Hold
8,030
0.05% 109
2014
Q4
$773K Hold
8,030
0.05% 111
2014
Q3
$639K Buy
8,030
+330
+4% +$26K 0.04% 112
2014
Q2
$580K Sell
7,700
-200
-3% -$15.1K 0.04% 102
2014
Q1
$591K Hold
7,900
0.03% 117
2013
Q4
$565K Buy
7,900
+500
+7% +$32.1K 0.03% 116
2013
Q3
$420K Buy
7,400
+100
+1% +$5.96K 0.03% 125
2013
Q2
$417K Buy
+7,300
New +$423K 0.03% 119

Other funds holding CVS

TCTC Holdings's CVS Position: Q1 2026 in Review

TCTC Holdings increased its CVS Health (CVS) stake by 0.19% in Q1 2026, buying an estimated $53.9K and bringing the position to 369,627 shares worth $26.5M. The position accounts for 0.76% of the portfolio, ranked #34.

TCTC Holdings first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $47.7M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • TCTC Holdings held 369,627 shares of CVS Health worth $26.5M as of Q1 2026.
  • TCTC Holdings bought 700 CVS Health shares in Q1 2026, an estimated $53.9K.
  • CVS Health made up 0.76% of TCTC Holdings's portfolio in Q1 2026, its #34 holding.
  • TCTC Holdings first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • TCTC Holdings's CVS Health position peaked at $47.7M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on TCTC Holdings's 13F filing for Q1 2026, filed 7 May 2026.